🇺🇸 FDA
Patent

US 8420694

Pyrrolidin-2-one derivatives as androgen receptor modulator

granted A61PA61P13/08A61P15/00

Quick answer

US patent 8420694 (Pyrrolidin-2-one derivatives as androgen receptor modulator) held by Takeda Pharmaceutical Company Limited expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P13/08, A61P15/00, A61P15/10, A61P15/12